The rising incidence of stroke in the young: Epidemiology,causes and global impact

Abstract

Although reductions in stroke incidence have been reported over recent decades particularly in high-income countries, there has been a worrying trend since the start of the 21st century: stroke incidence in younger individuals (<55 years) has not showed a similar decrease as at older ages. In high-income countries, several population-based studies have found an increase in the incidence of stroke at younger ages since 2000, reaching up to 90% in Oxfordshire, UK (2010–2018 vs 1981–1986) and 97% in Cincinnati, USA (2010 vs 1993–1994). A similar picture has also been documented in low- and middle-income countries, both in population-based studies (Joinville, Brazil, 35% increase in 2012–2013 vs 2005–2006) and in the Global Burden of Disease study. The exact reasons for this very different picture seen in younger individuals are unknown. One possibility is that traditional modifiable risk factors are increasingly prevalent and often undertreated at younger ages. However, studies have also found increases in the incidence of young-onset cryptogenic stroke and in people with no traditional modifiable risk factors, suggesting a role for emerging risk factors. Potential culprits might include air pollution, long working hours, psychosocial stress, prior autoimmune diseases, and illicit drug use, although further research is required to determine whether these emerging risk factors are causally related to stroke at younger ages. Without further intervention, the global burden of stroke at younger ages is projected to increase further in the coming years. Therefore, there is an urgent need to better understand the drivers of these time trends in incidence, to potentially alleviate the individual and societal impacts of stroke in the young. In this narrative review, we examine the recent global changes in stroke epidemiology at younger ages, their potential drivers, and their projected consequences.

Keywords

Epidemiology risk factors prevention young stroke stroke incidence burden

Introduction

Stroke is traditionally considered a disease of older ages. In high-income countries (HICs), the median age at the time of a first-ever stroke is over 70 years,¹ and only 5–15% of cases occur at younger ages (commonly defined as <55 years).^2–5 In low- and middle-income countries (LMICs), patients with stroke are on average 5 years younger than in HICs,⁶ with a higher proportion of cases occurring at younger ages, ranging from 14% to 24%.^7–10

Recently, multiple studies have reported an increase in stroke incidence at younger ages, which contrasts with the decrease in stroke incidence at older ages and parallels trends in early-onset cancer and mortality.^11–13 The exact reasons for this increase are unknown, with potential contributions of traditional and emerging vascular risk factors. This increase is projected to have important public health consequences due to the economic costs of stroke at younger ages and its impacts on disability, quality of life, and premature mortality. A review of the changing landscape of stroke epidemiology at younger ages is necessary to contextualize recent trends and generate mechanistic hypotheses. In this review, we aimed to provide an up-to-date summary of recent trends in stroke incidence at younger ages as well as to discuss their potential drivers and consequences.

Incidence: a changing landscape

The landscape of stroke incidence at younger ages has changed in the last two decades, with different trends compared to stroke at older ages and marked disparities between HICs and LMICs (Figure 1).

Figure 1.

Age-standardized incidence of stroke at ages 20–54 years according to 2021 estimates from the Global Burden of Disease study. Incidence rates age-standardized by 5-year age groups to the world standard population.

HICs

Due to improvements in primary prevention, stroke incidence decreased overall at an annual rate of 1.0–1.5% in HICs between 1985 and 2017.¹⁴ However, this mostly resulted from a decrease at older ages. A recent systematic review found that of 36 population- or administrative-based studies reporting at least one period after 2000, more than half (n = 24) showed an increase in stroke incidence at younger ages.¹³ The rest reported stable or declining rates. Part of the heterogeneity was explained by differences in study methodology. Incidence rates increased in the five population-based studies that used constant methods to maximize the ascertainment of minor events, which make up a larger proportion of strokes at younger than at older ages.^13,15 In these studies, the absolute increase in incidence ranged from 21% to 97%,^2,5,13,16,17 with the most prominent rise in the United States. Few studies reported time trends stratified by etiology. In the Oxford Vascular study (OxVasc), the greatest absolute increases were in cryptogenic events and small-vessel occlusion, with stable rates of rare causes like arterial dissection.³ According to the 2021 Global Burden of Disease (GBD) study, the median age-standardized incidence rate (ASIR, world standard population) of stroke at ages 20–54 years in HICs was 42.0 per 100,000 person-years (interquartile range (IQR): 31.4–55.1), with the lowest rates in Luxembourg (22.5) and Italy (22.9) and the highest rates in the United Arab Emirates (81.8) and Nauru (180.7).¹⁸

Although time trends in absolute incidence rates were heterogeneous, the same systematic review showed a consistent age-specific divergence. Nearly all studies found that stroke incidence evolved less favorably at younger than at older ages. Even in studies where young stroke incidence decreased over time, this was to a lesser extent than at older ages (Table 1). Similar findings were identified irrespective of the definition of young stroke (<45 or <55 years), stroke subtype, sex, race, or ethnicity.¹³

Table 1.

Time trends in stroke incidence at ages <55 years and time trends in age-specific stroke incidence at younger versus older ages in recent population-based studies.

Name	Time periods	IRR (95% CI)	RTTR (95% CI)
North America
Texas, USA	2017 vs 2000	1.14 (0.82–1.59)	1.67 (1.18–2.36)
Cincinnati, Ohio, USA	2010 vs 1993–1994	1.97 (1.67–2.32)	2.62 (2.19–3.13)
Europe
Oxfordshire, UK	2010–2018 vs 1981–1986	1.90 (1.37–2.65)^a	2.63 (1.86–3.72)
South London, UK	2012–2015 vs 2000–2003	0.85 (0.63–1.14)^a	1.60 (1.17–2.21)
Orebro, Sweden	2017 vs 1999	0.76 (0.41–1.41)	1.68 (0.89–3.20)
Lund, Sweden	2015–2016 vs 2001–2002	0.88 (0.54–1.46)	1.26 (0.75–2.11)
Dijon, France	2003–2011 vs 1985–1993	1.74 (1.39–2.19)	1.52 (1.19–1.93)
Valle d’Aosta, Italy	2004–2008 vs 1989	1.12 (0.70–1.80)	1.46 (0.89–2.40)
Porto, Portugal	2009–2011 vs 1998–2000	0.80 (0.57–1.13)	1.03 (0.71–1.50)
Arcadia, Greece	2015–2016 vs 1993–1995	1.08 (0.63–1.85)	1.07 (0.61–1.86)
Tartu, Estonia	2001–2003 vs 1991–1993	0.69 (0.47–0.99)^a	0.74 (0.51–1.07)
The rest of the world
Auckland, New Zealand	2011–2012 vs 2002–2003	1.50 (1.19–1.89)	2.10 (1.64–2.68)
Martinique, French West Indies	2011–2012 vs 1998–1999	1.21 (0.89–1.64)	1.88 (1.35–2.61)
Takashima, Japan	1999–2001 vs 1990–1992	1.19 (0.71–1.98)	1.26 (0.74–2.16)
Joinville, Brazil	2012–2013 vs 2005–2006	1.35 (1.12–1.64)	1.74 (1.52–1.96)
Matão, Brazil	2015–2016 vs 2003–2004	0.65 (0.27–1.57)	1.42 (0.53–2.31)

IRR: incidence rate ratio; RTTR: relative temporal trend ratio; IRRs were calculated at ages < 55 years, with IRR > 1 indicating an increase in the later time periods. RTTRs were calculated for younger versus older age groups with RTTR > 1 indicating a less favorable trend at younger ages.

Age- and sex-standardized IRRs. Studies referenced for this table are listed in the Supplemental Web Appendix.

In studies where young stroke incidence increased, this mainly occurred during the first decade of the 21st century.¹³ Recent population-based studies suggested that incidence rates may have stabilized after 2010 but not returned to their previous level.^3,16,19 The potential impact of the COVID-19 pandemic on young stroke incidence is unknown, with more difficult ascertainment of minor events, potential setbacks in primary prevention, and the occurrence of young stroke cases due to SARS-CoV-2 infection.²⁰

LMICs

The burden and features of young stroke differ in LMICs compared to HICs. In the INTERSTROKE study, the proportion of patients aged ⩽45 years was higher in countries from Africa (21%) or Southeast Asia (18%) compared to Western Europe, North America or Australia (7%).²¹ The distribution of young stroke subtypes also varied by region, with a larger proportion of intracerebral hemorrhage (ICH) in South America (46% of all strokes), Southeast Asia (39%), or Africa (32%) compared to Western Europe, North America, or Australia (5%).²²

Young stroke incidence rates are generally higher in LMICs than in HICs. A population-based study from Iquique (Chile) found that the ASIR of stroke at ages < 54 years was 20.7 per 100,000 person-years in 2000–2002.⁷ In China, a nationwide survey in 2013 estimated an ASIR of stroke at ages 20–49 years of 42.4 per 100,000 person-years.²³ In a population-based study from Tanzania (2003–2006), the ASIR of stroke at ages < 54 years was substantially higher at 79.8 per 100,000 person-years, highlighting important inequalities between countries.⁸ The GBD study suggested these disparities partly reflect differences in social and economic development. Stratifying 2021 GBD estimates by socio-demographic index (SDI), the ASIR of stroke at ages 20–54 years were 44.8 (high SDI), 66.6 (middle SDI), and 73.4 (low SDI) per 100,000 person-years.¹⁸

Unfavorable time trends in young stroke incidence have also been identified in LMICs. Globally, the GBD study found that the ASIR of stroke at ages 20–54 years decreased between 1990 and 2015 but then mildly increased between 2015 and 2019 (Figure 2).¹⁸ This reversal was more pronounced for ischemic stroke and in countries with a high-middle or middle SDI. There was also a hint that young stroke incidence may have decreased between 2019 and 2021. Further data are needed to determine whether this was a true reduction or the result of under-ascertainment during the COVID-19 pandemic.

Figure 2.

Time trends in age-standardized incidence of stroke at ages 20–54 years according to the Global Burden of Disease study (1990–2021), stratified by socio-demographic index. Incidence rates age-standardized by 5-year age groups to the world standard population and reported per 100,000 person-years. ASIR: age-standardized incidence rate; SDI: socio-demographic index.

At a country level, few population-based studies from LMICs have reported time trends in young stroke incidence.^10,24–28 In Joinville (Brazil), stroke incidence increased by 88% at ages < 45 years from 2005–2006 to 2010–2011, with subsequently stable rates in 2014–2015.²⁶ This increase concerned ischemic stroke and ICH, was more pronounced for small-vessel occlusion, and contrasted with a decrease in stroke incidence at older ages.^26,29 In Tianjin (China), stroke incidence at ages 35–54 years increased by twofold to threefold between 1992 and 2015.²⁷ Other population-based studies have reported conflicting results. In Matão (Brazil), young stroke incidence possibly decreased in 2015–2016 compared to 2003–2004, but only 23 events were recorded across both time periods.¹⁰ Interestingly, a divergence by age was still found, confirming a less favorable trend at younger compared to older ages. In Tartu (Estonia), young stroke incidence decreased in 2013–2017 and 2001–2003 compared to 1991–1993, with no apparent age-specific divergence.²⁸ However, young stroke incidence was much higher in Estonia than in other European HICs in 1991–1993. This decline in incidence coincided with a period of important economic growth, with Estonia classified as a HIC by the World Bank since 2006. These changes could have improved primary prevention, causing stroke incidence rates at younger ages in Estonia to decrease closer to the level of other European HICs.

Mechanisms: measurement artifact or true increase in incidence?

Given the alarming increase in stroke incidence at younger ages, there is a crucial need to better understand its main drivers, with several possible hypotheses.

Chance or artifact?

The consistently unfavorable time trends in young stroke incidence across studies make a chance finding unlikely, with an age-specific divergence found in countries that have markedly different healthcare systems, methods of measuring incidence, and distribution of stroke subtypes.

In HICs, the increased incidence in administrative or registry-based studies could have resulted from improved coding of stroke over time or more frequent hospital management of young patients.³⁰ However, similar time trends in incidence were found in population-based studies that used constant methods of ascertainment and included patients diagnosed in all settings. Even though ischemic stroke has transitioned from a time- to a tissue-based definition, population-based studies continued using the time-based definition in recent time periods. Moreover, several studies found an increase in the incidence of both transient ischemic attack (TIA) and stroke at younger ages, suggesting that the observed time trends did not result from a diagnostic drift from TIA to stroke.^3,13 Identification of strokes may have improved due to better recognition of stroke symptoms and more widespread use of magnetic resonance imaging (MRI). However, these changes were not specific to young people. Moreover, the Greater Cincinnati Northern Kentucky study showed that the use of MRI may not substantially change stroke incidence estimates, as incorporating MRI findings “rules out” almost the same number of strokes as it “rules in.”³¹ Furthermore, the increase in incidence at younger ages was not limited to minor ischemic events, with OxVasc finding increased rates of major or disabling stroke and ICH in 2010–2018 compared to 2002–2010.³

In LMICs, there have been few ideal population-based studies with consistent and near-complete ascertainment of stroke over time. Consequently, trends in young stroke incidence may be more difficult to interpret, as there have been important variations across settings in patient behavior, diagnostic practices, and access to neuroimaging.

Traditional modifiable risk factors?

In contrast to the historical view that traditional modifiable stroke risk factors (Figure 3) are mainly relevant at older ages, their role is increasingly recognized at younger ages, as they are frequent and strongly associated with stroke in the young.³² In a German nationwide study, 47% of young stroke patients were current smokers, 45% had known hypertension, 31% had hyperlipidemia, 22% were obese, and 10% had diabetes.³² Similarly high prevalence rates were found in recent studies from the United Kingdom and the United States.^3,33 The relative association between certain traditional modifiable risk factors and stroke tends to be stronger at younger compared to older ages, including hypertension, obesity, and diabetes.^34,35 Consequently, these risk factors are responsible for a large proportion of strokes at younger ages. In the INTERSTROKE study, the population attributable risk (PAR) of 10 traditional modifiable risk factors was 92.2% for stroke at ages ⩽ 55 years, with the highest PAR found for hypertension (49.7%) and lack of regular physical activity (35.3%).²¹ Hypertension had a higher PAR for ICH than ischemic stroke, but estimates for other risk factors were similar across aetiological subtypes of ischemic stroke.^22,32 The role of traditional modifiable risk factors increased with age, but they still had a considerable contribution at the youngest end of the age spectrum. In INTERSTROKE, the PAR for hypertension was 23.3% at ages < 35 years.²²

Figure 3.

Time trends of traditional and emerging risk factors for stroke at younger ages in high-income and low- and middle-income countries. HIC: high-income countries; LMIC: low- and middle-income countries. Studies referenced for this table are listed in the Supplemental Web Appendix.

Time trends in the prevalence of traditional modifiable risk factors have been variable (Figure 3). While hypertension has been stable or decreasing in HICs, diabetes and obesity have become increasingly prevalent at younger ages over the past 30 years.^3,36–38 An analysis of the GBD study suggested that high body mass index and high fasting plasma glucose were two of the three main contributors to the increase in disability adjusted life years attributable to ischemic stroke at younger ages between 1990 and 2019.³⁹

In addition to their high prevalence, traditional modifiable risk factors tend to increasingly cluster in young patients with stroke, particularly in men. In a large Dutch cohort, 35% of patients aged < 55 years with ischemic stroke and 30% with ICH had two or more modifiable risk factors.⁴⁰ In the Florida stroke registry, the proportion of patients with three or more traditional modifiable risk factors increased from 34.6% in 2014 to 41.9% in 2022 at ages 36–55 years, and from 10.9% to 16.4% at ages 18–35 years.³³

Even though they are highly prevalent at younger ages, traditional modifiable risk factors are often unknown or undertreated.⁴¹ Young people are less likely to be aware and treated for their hypertension than older individuals, resulting in lower likelihood of blood pressure control in both high- and low-income settings.⁴² Similar age-related gaps in awareness and treatment have also been reported for diabetes.⁴³ Part of this phenomenon might be related to current risk model-based management approaches in primary prevention.⁴⁴ Given the heavy influence of age in existing models, it is perhaps not surprising that young people (particularly young women) are usually predicted to be below current treatment thresholds despite having elevated blood pressure or cholesterol levels. This may reduce the incentive to screen for risk factors and initiate primary prevention measures at younger ages. Conversely, management of risk factors may have preferentially improved at older ages (e.g. increased use of direct anticoagulants for atrial fibrillation), contributing to an age-specific divergence in stroke incidence.⁴⁵

Data were sparse regarding traditional modifiable risk factors in young people with stroke from LMICs. The GOAL initiative showed that stroke patients in LMICs tended to be younger with fewer traditional modifiable vascular risk factors than in HICs, although hypertension and diabetes were more prevalent in Black (hypertension, 52.1%; diabetes, 20.7%) and Asian patients (hypertension 46.1%, diabetes, 20.9%).⁴⁶ Ninety-percent of people with ischemic stroke aged < 50 years had hypertension in a multicentric study from Nigeria and Ghana, with two-thirds of events attributed to large artery-atherosclerosis or small-vessel disease.⁴⁷ Different trends in the prevalence and control of traditional modifiable risk factors are likely responsible for some of the inequalities in young stroke incidence between HICs and LMICs. The Non-Communicable Diseases Risk Factor Collaboration showed that the age-standardized prevalence of hypertension increased between 1990 and 2019 in most LMICs compared to HICs.⁴⁸ In the PURE cohort study, the prevalence of hypertension in participants aged < 50 years was similar in LMICs and HICs, but the rates of blood pressure treatment and control were lower in LMICs.⁴² Similar inequalities were reported for diabetes, with the lowest treatment rates in sub-Saharan Africa and South Asia.⁴⁹ In addition to increasing rates of non-communicable diseases, LMICs still face an important burden of communicable diseases (e.g. rheumatic heart disease, human immunodeficiency virus), which may contribute to geographical disparities in stroke incidence.

Traditional modifiable risk factors are undoubtedly important contributors to stroke at younger ages. However, they might not be the main mechanistic driver for the observed time trends in stroke incidence. In OxVasc, the relative increase in stroke incidence at younger ages was also seen in people without hypertension, diabetes, or smoking, with the largest absolute increases seen in people with none of these risk factors and in cryptogenic stroke. There was also a simultaneous decrease in the incidence of myocardial infarction and peripheral vascular events at younger ages, suggesting that atherosclerosis was unlikely to be the main cause of the increase in young strokes.³

Emerging risk factors?

Several non-traditional risk factors (Figure 3) have emerged as potential contributors to the unfavorable time trends in stroke incidence reported at younger ages. In this review, we examined some of these emergent risk factors and their potential contribution to stroke at younger ages. Further research is warranted to determine whether these associations were causal and specific to young patients.

Acute and chronic exposure to air pollution has been associated with an increased risk of stroke. The PURE study found a dose–response relationship between chronic exposure to outdoor particulate matter 2.5 and the rates of cardiovascular events during follow-up, with a stronger association (hazard ratio per 10 μg/m³ increase of particulate matter 2.5 = 1.07) and a higher PAR (19.6%) for stroke compared to myocardial infarction.⁵⁰ Although no interaction with age was reported in PURE,⁵⁰ a study from Israel suggested that the association between air pollution and stroke was only present in people aged < 55 years.⁵¹ Globally, the GBD study estimated that in 2021, ambient particulate matter pollution was the second largest contributor to stroke disability-adjusted life years (DALYs).⁵² Other environmental exposures have also been associated with stroke, including rising ambient temperatures across the globe and household pollution related to kerosene or solid fuel use in LMICs, but data were not stratified by age.^52,53

Work-related factors have also been suggested to be potential risk factors for stroke at younger ages. A large individual patient data meta-analysis found that long working hours were more strongly associated with an increased risk of stroke than of myocardial infarction, with a dose-response relationship past 40 h per week.⁵⁴ High levels of leisure sedentary time have been associated with stroke in the subset of young people with low levels of physical activity.⁵⁵ Acute and chronic psychosocial stress may also be an important contributor. In the SECRETO study, self-perceived stress was associated with an increased risk of cryptogenic ischemic stroke at ages 18–49 years, even after adjustment for traditional vascular risk factors.⁵⁶

Other emerging risk factors that have shown increasing trends in incidence and preferential associations with stroke at younger ages include prior autoimmune disease,⁵⁷ depression,⁵⁸ and illicit drug use.⁵⁹ Early-onset cancer has also become more frequent in the 21^st century, reflecting the existence of shared risk factors with stroke at younger ages (e.g. obesity, poor diet), and potentially impacting the incidence of cancer-associated stroke.¹²

Long-term impact: multifaceted questions

Will I survive?

Among young patients, short term case fatality after stroke increases with age and is higher after ICH than ischemic stroke.⁶⁰ Several population-based studies have found improvements over time.^60,61 In England, case fatality after stroke at ages 20–54 years decreased by 7.2% between 2001 and 2010.⁶⁰ However, other studies reported stagnating measures of case fatality.⁶² There are also significant regional disparities. In the GOAL initiative, 1-month case fatality after ischemic stroke at ages 18–50 years was 1.7% in HICs and 7.7% in LMICs.⁴⁶ A hospital-based study in Mozambique (2005–2006) found that 28-day mortality was 19.1% and 53.6% at ages < 45 years after ischemic stroke and ICH, respectively.⁶³

Data on long-term survival are more limited. In the FUTURE study, 30-day young stroke survivors had a 3.9-fold excess risk of death during the subsequent 20 years compared to the general population.⁶⁴ The Swedish Inpatient Register (1987–2006) showed a decrease in 4-year mortality over time among 28-day young ischemic stroke survivors, but the latter remained at a sixfold higher risk of death than the general population.⁶⁵

Will I have another event?

Young stroke survivors are at high risk of recurrent stroke and other cardiovascular events. After an ischemic stroke, the 15-year cumulative risk of recurrent stroke was 16.4% in the FUTURE study⁶⁶ and 19.1% in the Helsinki young stroke registry.⁶⁷ Limited data are available regarding time trends in stroke recurrence. In the Swedish Inpatient Register, the 4-year rate of hospitalization for recurrent ischemic stroke decreased by 55% in males and 59% in females between 1987–1991 and 2002–2006.⁶⁸ Conversely, a South Korean registry-based study found no improvement in the 1-year risk of recurrent stroke or TIA between 2011 and 2019.⁶² Overall, the risk of recurrent stroke is higher than of a subsequent cardiac or peripheral arterial event. In young people with atherosclerotic or cardioembolic stroke, both these risks are increased to a similar extent.^66,67 Young stroke survivors are also at risk of bleeding. In the FUTURE study, the 10-year cumulative risk of minor or major bleeding was 21.8% after an ischemic stroke or TIA. Predictors of bleeding included female sex (mainly due to gynecological bleeds) and older age (40–49 years).⁶⁹

Will I make a full recovery?

Stroke at younger ages is associated with several adverse long-term outcomes. In a South Korean registry-based study, 32% of young patients with an ischemic stroke were dead or disabled (modified Rankin scale ⩾ 2) at 3 months, with no improvements in functional outcomes between 2011 and 2019.⁶² In a meta-analysis, 44% of young stroke survivors had residual cognitive impairment after at least 6 months of follow-up (excluding aphasia). Visuoconstruction abilities and processing speed were more frequently and severely affected.⁷⁰ In the FUTURE study, after a mean follow-up of 9 years, 15% of young stroke survivors developed post-stroke epilepsy.⁷¹ Young stroke survivors are also at a threefold to fivefold higher risk of cancer diagnosis in the first year after the event compared to the general population.⁷² Moreover, psychosocial consequences are a frequent problem for these patients. In a recent meta-analysis, the pooled prevalence rates of post-stroke depression or anxiety symptoms were 31% and 39%, respectively.⁷³ Only half of working-age adults are back at work 1-year post-stroke. Financial stress is common and is related to loss of income and out-of-pocket costs for health services.^74,75 Unlike physical disability, impairment related to fatigue or cognitive impairment is often invisible to other people, limiting social reintegration and access to adequate support.⁷⁵

Projections and future directions

In 2021, the GBD study estimated that nearly 2.8 million people aged < 55 years developed an incident stroke globally. Eighty-nine percent of these events occurred in LMICs.¹⁸ The number of young stroke survivors is projected to significantly increase in the upcoming years.⁷⁶ The American Heart Association estimated that from 2020 to 2050, stroke prevalence in the United States will rise from 0.8% to 2.6% at ages 20–44 years, and 3.8% to 5.6% at ages 45–64 years.⁷⁶ An analysis of data from the GBD study projected that from 2020 to 2030, global stroke incidence rates will increase by a relative proportion of 11.8% at ages 20–39 years and 9.5% at ages 40–59 years.⁷⁷

While ongoing monitoring of age-specific stroke incidence across the globe remains crucial, concerted efforts are urgently needed to reduce the projected burden of stroke at younger ages. Given the high and increasing prevalence of modifiable traditional risk factors at younger ages, improvement in their prevention and control could have a meaningful impact on young stroke incidence.⁷⁷ Better risk prediction tools for young adults are also needed to facilitate the initiation and maintenance of primary prevention measures. Further research is still required to understand the mechanisms driving the age-specific divergence in stroke incidence rates, with a focus perhaps on the role of emerging risk factors and their potential synergistic effect with traditional risk factors and genetic susceptibility. Finally, while most studies reported data from HICs, research focused on LMICs is necessary to identify country-specific targets and strategies that could mitigate the impact of stroke at younger ages.

Supplemental Material

sj-docx-1-wso-10.1177_17474930251362583 – Supplemental material for The rising incidence of stroke in the young: Epidemiology, causes and global impact

Supplemental material, sj-docx-1-wso-10.1177_17474930251362583 for The rising incidence of stroke in the young: Epidemiology, causes and global impact by Ahmad Nehme and Linxin Li in International Journal of Stroke

Footnotes

Declaration of conflicting interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Dr Nehme is funded by the Oxford University Clarendon Scholarship and the Fonds de Recherche du Québec (); Dr Li is funded by the NIHR Advanced Fellowship and the Oxford Brain Science Fellowship.

ORCID iD

Linxin Li

Supplemental material

Supplemental material for this article is available online.

References

Rothwell

Coull

Giles

, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004; 363: 1925–1933.

Béjot

Daubail

Jacquin

, et al. Trends in the incidence of ischaemic stroke in young adults between 1985 and 2011: the Dijon Stroke Registry. J Neurol Neurosurg Psychiatry 2014; 85: 509–513.

Scott

Rothwell

PM.

Association of younger vs older ages with changes in incidence of stroke and other vascular events, 2002-2018. JAMA 2022; 328: 563–574.

Karantali

Vemmos

Tsampalas

, et al. Temporal trends in stroke incidence and case-fatality rates in Arcadia, Greece: a sequential, prospective, population-based study. Int J Stroke 2022; 17: 37–47.

Olindo

Chausson

Mejdoubi

, et al. Trends in incidence and early outcomes in a Black Afro-Caribbean population from 1999 to 2012: Etude Réalisée en Martinique et Centrée sur l’Incidence des Accidents Vasculaires Cérébraux II Study. Stroke 2014; 45: 3367–3373.

Rahbar

Medrano

Diaz-Garelli

, et al. Younger age of stroke in low-middle income countries is related to healthcare access and quality. Ann Clin Transl Neurol 2022; 9: 415–427.

Lavados

Sacks

Prina

, et al. Incidence, 30-day case-fatality rate, and prognosis of stroke in Iquique, Chile: a 2-year community-based prospective study (PISCIS project). Lancet 2005; 365: 2206–2215.

Walker

Whiting

Unwin

, et al. Stroke incidence in rural and urban Tanzania: a prospective, community-based study. Lancet Neurol 2010; 9: 786–792.

Cabral

Gonçalves

Longo

, et al. Trends in stroke incidence, mortality and case fatality rates in Joinville, Brazil: 1995-2006. J Neurol Neurosurg Psychiatry 2009; 80: 749–754.

10.

Minelli

Cabral

Ujikawa

, et al. Trends in the incidence and mortality of stroke in Matão, Brazil: the Matão Preventing Stroke (MAPS) study. Neuroepidemiology 2020; 54: 75–82.

11.

Dowd

Doniec

Zhang

Tilstra

US exceptionalism? International trends in midlife mortality. Int J Epidemiol 2024; 53: dyae024.

12.

Zhao

Sun

, et al. Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019. BMJ Oncol 2023; 2: e000049.

13.

Scott

Rothwell

PM.

Diverging temporal trends in stroke incidence in younger vs older people: a systematic review and meta-analysis. JAMA Neurol 2022; 79: 1036–1048.

14.

Scott

Rothwell

; Oxford Vascular Study. Trends in stroke incidence in high-income countries in the 21st century: population-based study and systematic review. Stroke 2020; 51: 1372–1380.

15.

Béjot

Mehta

Giroud

Rothwell

PM.

Impact of completeness of ascertainment of minor stroke on stroke incidence: implications for ideal study methods. Stroke 2013; 44: 1796–1802.

16.

Madsen

Khoury

Leppert

, et al. Temporal trends in stroke incidence over time by sex and age in the GCNKSS. Stroke 2020; 51: 1070–1076.

17.

Krishnamurthi

Barker-Collo

Parag

, et al. Stroke incidence by major pathological type and ischemic subtypes in the Auckland regional community stroke studies: changes between 2002 and 2011. Stroke 2018; 49: 3–10.

18.

Institute for Health Metrics and Evaluation. Global Health Data Exchange (GHDx). Seattle, WA: Institute for Health Metrics and Evaluation, University of Washington, 2021. https://vizhub.healthdata.org/gbd-results/ (accessed 25 February 2025).

19.

Béjot

Duloquin

Current and projected burden of ischemic cerebrovascular events: nationwide estimates from the Dijon stroke registry, France. J Am Heart Assoc 2025; 14: e037925.

20.

Nannoni

de Groot

Bell

Markus

HS.

Stroke in COVID-19: a systematic review and meta-analysis. Int J Stroke 2021; 16: 137–149.

21.

O’Donnell

Chin

Rangarajan

, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet 2016; 388: 761–775.

22.

Khan

Wasay

O’Donnell

, et al. Risk factors for stroke in the young (18-45 years): a case-control analysis of INTERSTROKE data from 32 countries. Neuroepidemiology 2023; 57: 275–283.

23.

Wang

Jiang

Sun

, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation 2017; 135: 759–771.

24.

Nuñez

Delfino

Asenjo-Lobos

, et al. Disparities in stroke incidence over time by sex and age in Latin America and the Caribbean region 1997 to 2021: a systematic review and meta-analysis. J Am Heart Assoc 2023; 12: e029800.

25.

Okekunle

Jones

Adeniji

, et al. Stroke in Africa: a systematic review and meta-analysis of the incidence and case-fatality rates. Int J Stroke 2023; 18: 634–644.

26.

Cabral

Freire

Conforto

, et al. Increase of stroke incidence in young adults in a middle-income country: a 10-year population-based study. Stroke 2017; 48: 2925–2930.

27.

Ning

Sun

Jiang

, et al. Increased stroke burdens among the low-income young and middle aged in rural China. Stroke 2017; 48: 77–83.

28.

Kõrv

Vibo

Kõrv

Declining first-ever stroke incidence rates in 15- to 54-year-old residents of Tartu, Estonia, from 1991 to 2017. Int J Stroke 2023; 18: 462–468.

29.

Cabral

Cougo-Pinto

Magalhaes

, et al. Trends of Stroke Incidence from 1995 to 2013 in Joinville, Brazil. Neuroepidemiology 2016; 46: 273–281.

30.

George

Tong

Bowman

BA.

Prevalence of cardiovascular risk factors and strokes in younger adults. JAMA Neurol 2017; 74: 695–703.

31.

Kleindorfer

Khoury

Alwell

, et al. The impact of Magnetic Resonance Imaging (MRI) on ischemic stroke detection and incidence: minimal impact within a population-based study. BMC Neurol 2015; 15: 175.

32.

Aigner

Grittner

Rolfs

Norrving

Siegerink

Busch

MA.

Contribution of established stroke risk factors to the burden of stroke in young adults. Stroke 2017; 48: 1744–1751.

33.

Shoskes

Zhou

Ying

, et al. Temporal trends in vascular risk factor burden among young adults with ischemic stroke: the Florida stroke registry. Neurology 2025; 104: e213447.

34.

Howard

Banach

Kissela

, et al. Age-related differences in the role of risk factors for ischemic stroke. Neurology 2023; 100: e1444–e1453.

35.

Nguyen

KTK

Gaynor

, et al. Impact of conventional stroke risk factors on early- and late-onset ischemic stroke: a Mendelian randomization study. Stroke 2025; 56: 640–648.

36.

Gakidou

, et al. Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet 2025; 405: 813–838.

37.

Magliano

Chen

Morton

, et al. Trends in the incidence of young-adult-onset diabetes by diabetes type: a multi-national population-based study from an international diabetes consortium. Lancet Diabetes Endocrinol 2024; 12: 915–923.

38.

Aggarwal

Yeh

Joynt Maddox

Wadhera

RK.

Cardiovascular risk factor prevalence, treatment, and control in US adults aged 20 to 44 years, 2009 to March 2020. JAMA 2023; 329: 899–909.

39.

Zhang

Liu

, et al. Global burden of ischemic stroke in young adults in 204 countries and territories. Neurology 2022; 100: e422–e434.

40.

Hauer

Ruigrok

Algra

, et al. Age-specific vascular risk factor profiles according to stroke subtype. J Am Heart Assoc 2017; 6: e005090.

41.

O’Donnell

Hankey

Rangarajan

, et al. Variations in knowledge, awareness and treatment of hypertension and stroke risk by country income level. Heart 2021; 107: 282–289.

42.

Chow

Teo

Rangarajan

, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013; 310: 959–968.

43.

Wang

, et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013; 310: 948–959.

44.

McCarthy

Rahimi

McEvoy

JW.

Age-stratified risk categories for cardiovascular disease prevention therapies. JAMA Cardiol 2024; 9: 1069–1070.

45.

Ding

Ebeling

Ziegler

Wennberg

Modig

Time trends in atrial fibrillation-related stroke during 2001-2020 in Sweden: a nationwide, observational study. Lancet Reg Health Eur 2023; 28: 100596.

46.

Jacob

Ekker

Allach

, et al. Global differences in risk factors, etiology, and outcome of ischemic stroke in young adults-a worldwide meta-analysis: the GOAL initiative. Neurology 2022; 98: e573–e588.

47.

Sarfo

Ovbiagele

Gebregziabher

, et al. Stroke among young west Africans: evidence from the SIREN (Stroke Investigative Research and Educational Network) large multisite case-control study. Stroke 2018; 49: 1116–1122.

48.

NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 2021; 398: 957–980.

49.

NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet 2024; 404: 2077–2093.

50.

Hystad

Larkin

Rangarajan

, et al. Associations of outdoor fine particulate air pollution and cardiovascular disease in 157 436 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet Planet Health 2020; 4: e235–e245.

51.

Yitshak Sade

Novack

Ifergane

Horev

Kloog

. Air pollution and ischemic stroke among young adults. Stroke 2015; 46: 3348–3353.

52.

GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 2024; 23: 973–1003.

53.

Yusuf

Joseph

Rangarajan

, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet 2020; 395: 795–808.

54.

Kivimäki

Jokela

Nyberg

, et al. Long working hours and risk of coronary heart disease and stroke: a systematic review and meta-analysis of published and unpublished data for 603,838 individuals. Lancet 2015; 386: 1739–1746.

55.

Joundi

Patten

Williams

JVA

Smith

EE.

Association between excess leisure sedentary time and risk of stroke in young individuals. Stroke 2021; 52: 3562–3568.

56.

Kutal

Tulkki

Sarkanen

, et al. Association between self-perceived stress and cryptogenic ischemic stroke in young adults: a case-control study. Neurology 2025; 104: e213369.

57.

Conrad

Verbeke

Molenberghs

, et al. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet 2022; 400: 733–743.

58.

Salaycik

Kelly-Hayes

Beiser

, et al. Depressive symptoms and risk of stroke: the Framingham Study. Stroke 2007; 38: 16–21.

59.

de los Ríos

Kleindorfer

Khoury

, et al. Trends in substance abuse preceding stroke among young adults: a population-based study. Stroke 2012; 43: 3179–3183.

60.

Seminog

Scarborough

Wright

Rayner

Goldacre

MJ.

Determinants of the decline in mortality from acute stroke in England: linked national database study of 795 869 adults. BMJ 2019; 365: l1778.

61.

Bejot

Rouaud

Durier

, et al. Decrease in the stroke case fatality rates in a French population-based twenty-year study. Cerebrovasc Dis 2007; 24: 439–444.

62.

Kim

Kang

, et al. Improvement in delivery of ischemic stroke treatments but stagnation of clinical outcomes in young adults in South Korea. Stroke 2023; 54: 3002–3011.

63.

Gomes

Damasceno

Carrilho

, et al. Determinants of early case-fatality among stroke patients in Maputo, Mozambique and impact of in-hospital complications. Int J Stroke 2013; 8: 69–75.

64.

Rutten-Jacobs

Arntz

Maaijwee

, et al. Long-term mortality after stroke among adults aged 18 to 50 years. JAMA 2013; 309: 1136–1144.

65.

Giang

Björck

Nielsen

, et al. Twenty-year trends in long-term mortality risk in 17,149 survivors of ischemic stroke less than 55 years of age. Stroke 2013; 44: 3338–3343.

66.

Rutten-Jacobs

Maaijwee

Arntz

, et al. Long-term risk of recurrent vascular events after young stroke: the FUTURE study. Ann Neurol 2013; 74: 592–601.

67.

Aarnio

Siegerink

Pirinen

, et al. Cardiovascular events after ischemic stroke in young adults: a prospective follow-up study. Neurology 2016; 86: 1872–1879.

68.

Giang

Björck

Ståhl

, et al. Trends in risk of recurrence after the first ischemic stroke in adults younger than 55 years of age in Sweden. Int J Stroke 2016; 11: 52–61.

69.

Verhoeven

Van Lith

Ekker

, et al. Long-term risk of bleeding and ischemic events after ischemic stroke or transient ischemic attack in young adults. Neurology 2022; 99: e549–e559.

70.

Weterings

Kessels

de Leeuw

Piai

Cognitive impairment after a stroke in young adults: a systematic review and meta-analysis. Int J Stroke 2023; 18: 888–897.

71.

Arntz

Rutten-Jacobs

Maaijwee

, et al. Post-stroke epilepsy in young adults: a long-term follow-up study. PLoS ONE 2013; 8: e55498.

72.

Verhoeven

Fan

Broeders

MJM

, et al. Association of stroke at young age with new cancer in the years after stroke among patients in the Netherlands. JAMA Netw Open 2023; 6: e235002.

73.

Ignacio

KHD

Muir

Diestro

JDB

, et al. Prevalence of depression and anxiety symptoms after stroke in young adults: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis 2024; 33: 107732.

74.

Edwards

Kapoor

Linkewich

Swartz

RH.

Return to work after young stroke: a systematic review. Int J Stroke 2018; 13: 243–256.

75.

Demers

Charalambous

Kwah

, et al. Unique needs and challenges experienced by young people with stroke: an international qualitative analysis. Neurol Clin Pract 2025; 15: e200406.

76.

Joynt Maddox

Elkind

MSV

Aparicio

, et al. Forecasting the burden of cardiovascular disease and stroke in the United States through 2050-prevalence of risk factors and disease: a presidential advisory from the American Heart Association. Circulation 2024; 150: e65–e88.

77.

Wang

Zhang

, et al. Projected global trends in ischemic stroke incidence, deaths and disability-adjusted life years from 2020 to 2030. Stroke 2023; 54: 1330–1339.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.02 MB